URL copied to clipboard

Trending News

Tata Chemicals Q2 Profit Drops 46% But Beats Estimates – Find Out Full News!

Tata Chemicals' Q2 net profit dropped 46% YoY to ₹267 crore, down from ₹495 crore, but exceeded the projected ₹231 crore, despite challenges in demand across global markets.
Tata Chemicals Q2 Profit Drops 46% But Beats Estimates – Find Out Full News!

Tata Chemicals Ltd.’s consolidated net profit for the second quarter of the financial year fell 46% year-on-year to ₹267 crore, compared to ₹495 crore in the same period last year. However, the profit exceeded estimates, with the company having projected ₹231 crore for the quarter.

Alice Blue Image

Revenue remained flat at ₹3,999 crore versus ₹3,998 crore year-on-year. The company’s Ebitda dropped 25% to ₹618 crore, down from ₹819 crore, with margins shrinking to 15.5% from 20.5%. Despite the profit drop, Tata Chemicals noted stable demand across key industries in India.

Also read: Nestle India Q2 FY25 Net Profit Up 8.6% to ₹986.4 Crore!

While demand in India remained robust, especially for flat, container, and solar glass, imports saw a decline. Conversely, demand in America dropped, and Europe witnessed muted demand. Nonetheless, Tata Chemicals reported a 6% sequential revenue increase, driven by higher volumes and realisations in soda ash.

Ebitda also rose 8% quarter-on-quarter, aided by improved margins in the US, Kenya, and Rallis. These regions contributed to the company’s stronger financial performance compared to the previous quarter, despite challenging market conditions in other regions.

Also read Central Bank of India Q2 Profit Soars 51% on Lower Provision!

The company highlighted that its net debt increased compared to the previous year, primarily due to lower Ebitda and higher working capital requirements in the US, UK, and India. Capitalisation of leases also contributed to the rise in debt levels.

Alice Blue Image

Tata Chemicals’ shares closed 2.41% lower at ₹1,073.85 on the NSE, underperforming the Nifty 50, which fell by 0.89%. Despite the decline in profits and shares, the company managed to surpass market expectations.

Loading
Read More News

फार्मा स्टॉक में उछाल, ₹177 करोड़ के ब्राउनफील्ड प्रोजेक्ट के लिए कैपेक्स की घोषणा की।

फार्मा स्टॉक ने झगड़िया में ₹177 करोड़ का अपग्रेड प्लान किया है, जिससे संचालन ऑटोमेट होगा और इलेक्ट्रोलाइट एडिटिव्स सुविधा